Jess, I am expecting that the next 18 months will more than compensate us for the last 2 and three quarter years. You deserve credit for maintaining throughout that Ariad would persevere and thrive which it is starting to do. Regarding a modification of the label for Ponatinib, how soon do you see this happening? That change will be a key catalyst in bringing the sp back to its former highs imo.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.